**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 100-02-7 |p-Nitrophenol | 98% | 202-811-7 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 33
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed. Danger
of cumulative effects.
Potential Health Effects
Eye:
Causes severe eye irritation.
Skin:
Causes severe skin irritation. If absorbed, causes symptoms similar
to those of ingestion.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with
nausea, vomiting and diarrhea. May cause kidney damage. May cause
central nervous system depression, characterized by excitement,
followed by headache, dizziness, drowsiness, and nausea. Advanced
stages may cause collapse, unconsciousness, coma and possible death
due to respiratory failure. May cause methemoglobinemia, cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood), convulsions, and death. Methemoglobinemia is characterized
by dizziness, drowsiness, headache, breath shortness, cyanosis with
bluish skin, rapid heart rate and chocolate-brown colored blood. May
cause cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood). Ingestion may produce shock, collapse,
and convulsions.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to
those described for ingestion.
Chronic:
Chronic inhalation and ingestion may cause effects similar to those
of acute inhalation and ingestion.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of soap and
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Remove contaminated clothing
and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure to fresh air
immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Absorption of this product into the body may cause cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood).
Moderate degrees of cyanosis need to be treated only by supportive
measures: bed rest and oxygen inhalation. For methemoglobinemia,
administer oxygen alone or with Methylene blue depending on the
methemoglobinemia concentration in the blood. Cleansing of the
entire contaminated area of the body is of utmost importance.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
Evacuate area and fight fire from a safe distance. As in any fire,
wear a self-contained breathing apparatus in pressure-demand,
MSHA/NIOSH (approved or equivalent), and full protective gear.
Combustion generates toxic fumes. Containers may explode in the heat
of a fire. Combustible material; even though it may take some effort
to ignite.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Remove all sources of
ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid contact with
heat, sparks and flame. Do not ingest or inhale. Wash clothing before
reuse.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Keep away from food
and drinking water. Keep from contact with oxidizing materials. Store
in a cool, dry, well-ventilated area away from incompatible
substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR
1910.134 or European Standard EN 149. Always use a
NIOSH or European Standard EN 149 approved respirator
when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Appearance: yellow
Odor: odorless
pH: Not available.
Vapor Pressure: .6 mm Hg @ 120 deg
Viscosity: Not available.
Boiling Point: 534 deg F
Freezing/Melting Point: 113.4 deg C
Autoignition Temperature: 541 deg F ( 282.78 deg C)
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Insoluble.
Specific Gravity/Density: 1.479 - 1.495
Molecular Formula: C6H5NO3
Molecular Weight: 139.0399
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials, temperatures above 125C.
Incompatibilities with Other Materials:
Strong oxidizing agents; Strong bases; Diethyl phosphite
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 100-02-7: SM2275000
LD50/LC50:
CAS# 100-02-7: Dermal, guinea pig: LD50 = >1 gm/kg; Oral, mouse:
LD50 = 282 mg/kg; Oral, rat: LD50 = 202 mg/kg; Skin, rat: LD50 = 1024
mg/kg.
Carcinogenicity:
p-Nitrophenol -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location. Contact a specialist disposal company or the local
waste regulator for advice. Empty containers must be decontaminated before
returning for recycling.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: p-NITROPHENOL
Hazard Class: 6.1
UN Number: 1663
Packing Group:
IMO
Shipping Name: p-NITROPHENOL
Hazard Class: 6.1
UN Number: 1663
Packing Group:
RID/ADR
Shipping Name: p-NITROPHENOL
Dangerous Goods Code: 6.1(12C)
UN Number: 1663
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 33 Danger of cumulative effects.
Safety Phrases:
S 28 After contact with skin, wash immediately
with...
WGK (Water Danger/Protection)
CAS# 100-02-7: 2
United Kingdom Occupational Exposure Limits
Canada
CAS# 100-02-7 is listed on Canada's DSL List.
CAS# 100-02-7 is listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 100-02-7: Not available.
US FEDERAL
TSCA
CAS# 100-02-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 5/14/1998 Revision #3 Date: 8/02/2000
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Methylalanine, 97% (titr.)
| 62-57-7 |
|
2,2'-Biquinoline, 98%
| 119-91-5 |
|
Zinc cyclohexanebutyrate dihydrate
| 38582-18-2 |
|
d-(+)-Mannose, 99+%
| 3458-28-4 |
|
N-Benzylidenemethylamine, 99%
| 622-29-7 |
|
p-Nitrophenol
| 100-02-7 |
|
3-Endo-Aminobicyclo??2.2.1??Heptane-2-Endo-Carboxylic Acid Monohydrate,
| 104308-53-4 |
|
2-Naphthyl-beta-D-galactopyranoside
| 33993-25-8 |
|
Triethylborane, 1M solution in THF
| 97-94-9 |
|
cis-4-Methyl-2-pentene, 99%
| 691-38-3 |
|
4-Bromoisophthalic Acid, 97%
| 6939-93-1 |
|
9,10-Dihydroanthracene, techn. 90%
| 613-31-0 |
|
Dodecyl isocyanate, 99%
| 4202-38-4 |
|
Nickel on Silica/Alumina, Catalyst, 64% Ni Reduced and Stabilized
| |
|
Trans-(-)-1,4-Di-O-Tosyl-2,3-0-Isopropylidene-L-Threitol, 97%
| 37002-45-2 |
|
Ethyl(ethoxymethylene)cyanoacetate, 98%
| 94-05-3 |
|
Nicotinamide Adenine Dinucleotide Trihydrate, 98% (UV-Vis)
| 53-84-9 |
|
DL-Methionine, 99%
| 59-51-8 |
|
3',4'-(Didecyloxy)benzaldehyde, 96%
| 118468-34-1 |
|
p-Xylene
| 106-42-3 |
|
3,4-Difluoroanisole, 98+%
| 115144-40-6 |
|
1-Phenylethyl propionate, 98+%
| 120-45-6 |
|
Palladium (II) Chloride
| 7647-10-1 |
|
1-Methyl-2-benzimidazolinone, 98%
| 1849-01-0 |
|
Pancreatin
| 8049-47-6 |
|
Paraformaldehyde
| 30525-89-4 |
|
Biphenyldimethylsilyl Chloride, 99%
| 0-00-1 |
|
1-Pentadecanol, 99+%
| 629-76-5 |
|
4-(Ethoxyfluorophosphinyloxy)-Tempo, Free Radical
| 37566-53-3 |
|
Sulfuric Acid-D2, 97% +/- 1% Solution in D2O, 99.5+ Atom % D
| 7789-20-0 |
|
trans-3-Hexene, 99+%
| 13269-52-8 |
|
1,1-Diethoxy-2-Cyanoethane, 95%
| 2032-34-0 |
|
Dl-Octopamine Hydrochloride, 98%
| 770-05-8 |
|
2,5-Dihydroxyphenylacetic Acid Gamma-Lactone, 97%
| 2688-48-4 |
|
4-Propoxyphenol, 96%
| 18979-50-5 |
|
(-)-Carvyl Acetate, Mixture of Isomers, 98+%
| 97-42-7 |
|
4-Bromobenzenesulfonyl Chloride, 98%
| 98-58-8 |
|
Sodium Hyaluronate, 85%
| 9067-32-7 |
|
5-Hydroxyisoquinoline, tech., 90%
| 2439-04-5 |
|
Poly(4-Chlorostyrene)
| 24991-47-7 |
|
(r)-(-)-2-Phenylpropionic acid, 99%
| 7782-26-5 |
|
Nitro-L-Arginine, 99+%(E.E.)
| 2149-70-4 |
|
Dl-serine, 99%
| 302-84-1 |
|
N, N-Bis-(2,2-=Diethoxyethyl)-Methylamine, 97%
| 6948-86-3 |
|
Eriochrome Blue Black B
| 3564-14-5 |
|
D-Alanine, 99+%
| 338-69-2 |
|
Pinene (Pract)
| 80-56-8 |
|
2-Acetylcyclopentanone, 99%
| 1670-46-8 |
|
1-Benzyl-3-Carbethoxy-4-Piperidone Hydrochloride 97% (TLC)
| 1454-53-1 |
|
1,2-Propanediamine, 97% (titr.)
| 78-90-0 |
|
|